340B Drug discount program at-a-glance

| July 12, 2016

article image
In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Discount Program to help uninsured and vulnerable patients gain access to affordable prescription drugs. As part of the law, drug manufacturers provide discounts on outpatient medicines and treatments to select health care entities  often referred to as safety-net providers. The program was necessitated by changes to the Medicaid program that precluded drug makers from continuing to offer steep discounts to safetynet providers voluntarily, as they previously had done. Over the years, however, there have been growing concerns that this program has expanded well past the intent of Congress and that patients may not be seeing the benefits they deserve.

Spotlight

Strides Shasun Limited

Strides Shasun Limited, established in 1990, is a listed & professionally managed, fully integrated, global pharmaceutical company. With business footprints across pharmaceuticals (differentiated and branded generics), development and manufacturing (of intermediates, APIs and formulations) Strides Shasun is a valued player which manufactures and markets innovative branded generics and novel therapeutics that respond to health care needs worldwide.

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | March 2, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Spotlight

Strides Shasun Limited

Strides Shasun Limited, established in 1990, is a listed & professionally managed, fully integrated, global pharmaceutical company. With business footprints across pharmaceuticals (differentiated and branded generics), development and manufacturing (of intermediates, APIs and formulations) Strides Shasun is a valued player which manufactures and markets innovative branded generics and novel therapeutics that respond to health care needs worldwide.

Events